RT @EdEsplin: #universal #germline #genetictesting for all #patients w/ #breastcancer is extremely cost-effective for UK and US health syst…
RT @EdEsplin: #universal #germline #genetictesting for all #patients w/ #breastcancer is extremely cost-effective for UK and US health syst…
RT @EdEsplin: #universal #germline #genetictesting for all #patients w/ #breastcancer is extremely cost-effective for UK and US health syst…
RT @EdEsplin: #universal #germline #genetictesting for all #patients w/ #breastcancer is extremely cost-effective for UK and US health syst…
#universal #germline #genetictesting for all #patients w/ #breastcancer is extremely cost-effective for UK and US health systems, @JAMAOnc c/w @ASBrS guidelines & https://t.co/IaWG9jiRkI @JCO_ASCO & https://t.co/ZbAiKNyMLe @JAMANetworkOpen #BCAM2
RT @ProfManchanda: We earlier demonstrated this for UK and USA. https://t.co/QHYmCrnE5t @QMBCI @QMUL_WIPH_CPDD @LSHTM @QMULBartsTheLon @NHS…
We earlier demonstrated this for UK and USA. https://t.co/QHYmCrnE5t @QMBCI @QMUL_WIPH_CPDD @LSHTM @QMULBartsTheLon @NHSBartsHealth @eveappeal @BreastCancerNow @PKU1898
RT @ProfManchanda: https://t.co/QHYmCrnE5t Testing All women with breast cancer will prevent thousands more cancers and is cost effective…
RT @ProfManchanda: https://t.co/QHYmCrnE5t Testing All women with breast cancer will prevent thousands more cancers and is cost effective…
RT @ProfManchanda: https://t.co/QHYmCrnE5t Testing All women with breast cancer will prevent thousands more cancers and is cost effective…
RT @ProfManchanda: https://t.co/QHYmCrnE5t Testing All women with breast cancer will prevent thousands more cancers and is cost effective…
https://t.co/QHYmCrnE5t Testing All women with breast cancer will prevent thousands more cancers and is cost effective . See paper. https://t.co/Gu7KvBV4lU. @BrcaDirect critically imp study led by @clare__turnbull demonstrating implementation of this.
Agree, growing evidence of the 'Cost-effectiveness...of #Multigene Testing for All #Patients With #BreastCancer" #access #precisionmedicine #precisionprevention https://t.co/2p5T2knQUz https://t.co/pq6SAGd3X6
There is also evidence that this would be a cost effective intervention in the US context. https://t.co/KCk02ZvrBt #breastcancer #Genetics #valuebasedhealthcare
RT @SorenBentzen: BRCA1/BRCA2/PALB2 testing of all breast cancer patients (vs. based on family history) found to be cost-effective in a mic…
BRCA1/BRCA2/PALB2 testing of all breast cancer patients (vs. based on family history) found to be cost-effective in a microsimulation modeling study by Sun et al. from London School of Hygiene & Tropical Medicine https://t.co/xTTB1K3xkx
دراسةاختبار جيني متعدد لجميع مرضى سرطان الثدي فعال للغاية من حيث التكلفة مقارنة بالاختبارات التي تستند إلى تاريخ العائلة أو المعايير السريرية في المملكة المتحدة والولايات المتحدة. تدعم هذه النتائج تغيير السياسة الحالية لتوسيع الاختبارات الجينية لجميع النس
RT @JAMAOnc: Cost-effectiveness modeling study of 11,836 women, compared testing for BRCA1/BRCA2/PALB2 in unselected way to testing based o…
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer https://t.co/bvbOyFY7hn
RT @FabienReyal: #oncoalert how we translate this result in france and Europe?
RT @FabienReyal: #oncoalert how we translate this result in france and Europe? https://t.co/24LHMRivWr
RT @FabienReyal: #oncoalert how we translate this result in france and Europe?
RT @FabienReyal: #oncoalert how we translate this result in france and Europe?
RT @FabienReyal: #oncoalert how we translate this result in france and Europe? https://t.co/24LHMRivWr
#oncoalert how we translate this result in france and Europe?
Interesting cost effective study advocating mutation screening of breast cancer patients.
Intérêt financier du multiprofilage génétique de tout #cancerdusein indépendamment de l'histoire familiale. Quand la pêche au chalut fait mieux que la pêche à la ligne 😏 #çamedémange https://t.co/w2k1N08NyI
RT @SWexner: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/6Degi98mt6 @JAMAOnc @ASBrS @NAPBC_ACS…
RT @SWexner: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/6Degi98mt6 @JAMAOnc @ASBrS @NAPBC_ACS…
RT @caseofdees: 'Zeer kosteneffectief om alle borstkankerpatiënten op erfelijke aanleg voor borst/eierstokkanker te testen.' #brca #chek2 #…
RT @SWexner: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/6Degi98mt6 @JAMAOnc @ASBrS @NAPBC_ACS…
RT @SWexner: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/6Degi98mt6 @JAMAOnc @ASBrS @NAPBC_ACS…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
La secuenciación sin restricciones de BRCA1/2 & PALB2 en #CáncerDeMama resulta muy rentable. Se calculó que podrían salvarse miles de vidas/año. Los hallazgos respaldan la política de expandir las pruebas genéticas a todas las mujeres #breastcancer htt
RT @JAMAOnc: Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women w…
Multigene testing for all US and UK #breastcancer patients is cost-effective, suggesting this should be offered to all women with breast cancer https://t.co/UVj8VHfq0E
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
Study indicates a better approach to managing breast cancer, and demonstrates the value of lab medicine.
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
RT @BenWestphalen: Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧…
Provocative study in @JAMAOnc: Unrestricted sequencing 🧬 for BRCA1/2 & PALB2 in #bcsm is 💰 effective (based on 🇺🇸 & 🇬🇧 criteria). More importantly: The authors calculated that >3000 lives could be saved. #OncoAlert @MammaMiaMagazin https://
RT @SWexner: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/6Degi98mt6 @JAMAOnc @ASBrS @NAPBC_ACS…
#breat #cancer: #cost and multigene https://t.co/rmOOMpxKzG
Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/6Degi98mt6 @JAMAOnc @ASBrS @NAPBC_ACS @SocSurgOnc @ASCO
RT @DrPaulaGordon: https://t.co/unasFVd1sd Multigene Testing for All Patients With Breast Cancer is cost-effective, well below the UK and U…
RT @DrPaulaGordon: https://t.co/unasFVd1sd Multigene Testing for All Patients With Breast Cancer is cost-effective, well below the UK and U…
https://t.co/unasFVd1sd Multigene Testing for All Patients With Breast Cancer is cost-effective, well below the UK and US thresholds.
Already do this with Ovarian CA: "Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer" https://t.co/ZkAMfnxmHz
Yes, it is cost effective these days!! Great data!!
RT @CarlaFisherMD: I’ve been waiting for this data! A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast…
I’ve been waiting for this data! A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer | Breast Cancer | JAMA Oncology | JAMA Network https://t.co/Me0LdEiD6W
1 yr of testing all pts: prevent 2101 cases of #breastcancer/#ovariancancer & 633 deaths (UK); 9733 cases BC/OC & 2406 deaths (US). “Cost -effectiveness of Multigene Testing for ALL PATIENTS w/ #BreastCancer @JAMANetwork #oncology #genetictesting
まさにそう思います‼️
RT @MamMa_mimumemo: 英・米国からの報告。 遺伝性乳がんの検査は、家族歴などから絞って検査をするよりも、乳がん患者全員に行った方が、結果、多くの命が救え、さらに医療経済的にも良い。 日本にはそのまま使えないけど、国の医療政策って、本当はこうやって決めるものだ…
RT @JAMAOnc: Cost-effectiveness modeling study of 11,836 women, compared testing for BRCA1/BRCA2/PALB2 in unselected way to testing based o…
Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/tjeGXmGYH4
RT @22Kathryn11: Two different opinions about multi-gene panel testing of all women with BC. Broad Application of Multigene Panel Testing f…
Two different opinions about multi-gene panel testing of all women with BC. Broad Application of Multigene Panel Testing for Breast Cancer Susceptibility https://t.co/j5ocpHyIkL. Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer h
RT @FeliciaKnaul: Un análisis de costo-efectividad de las pruebas multigénicas para todas las pacientes con cáncer de mama podría beneficia…
Should all women with breast cancer be tested for BRCA? Probably...Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer https://t.co/Zh9eBK678R